What Do Hydroxychloroquine, Regeneron, and Remdesivir Have in Common?
They have all been prominently touted by Trump from March to the present day.
What Trump HASN'T touted is that he has profited substantially from the three drugs. The Office of Government Ethics has reported that Trump gained $50,000 to $100,000 from Regeneron Pharmaceuticals, and $100,000 to $1,000,000 from Gilead Sciences. Both are makers of Remdesivir and Regeneron.
Also reported: Trump's family investments have a large ownership in Sanofi, a major producer of Hydroxychloroquine.
It is more evidence that Trump has far more concern for his financial status than he does for the American public, now passing 210,000 deaths. Predictions are that 400,000 deaths will be realized by year's end. Trump, even today, continues to minimize the threat from the killer virus because the facts threaten his re-election efforts.